Search Results - "Rizell, M."

Influence of primary tumour and patient factors on survival in patients undergoing curative resection and treatment for liver metastases from colorectal cancer by Scherman, P., Syk, I., Holmberg, E., Naredi, P., Rizell, M.

“…Background Resection of the primary tumour is a prerequisite for cure in patients with colorectal cancer, but hepatic metastasectomy has been used increasingly…”
Get full text

Identification of Inequalities in the Selection of Liver Surgery for Colorectal Liver Metastases in Sweden by Norén, A., Sandström, P., Gunnarsdottir, K., Ardnor, B., Isaksson, B., Lindell, G., Rizell, M.

“…Background: Liver resection for colorectal liver metastases offers a 5-year survival rate of 25%–58%. This study aimed to analyze whether patients with…”
Get full text

Isolated Hepatic Perfusion for Ocular Melanoma Metastasis: Registry Data Suggests a Survival Benefit by Olofsson, R., Cahlin, C., All-Ericsson, C., Hashimi, F., Mattsson, J., Rizell, M., Lindnér, P.

“…Background Uveal melanoma is the most common primary intraocular malignancy in adults. Despite successful control of the primary tumor, metastatic disease will…”
Get full text

Treatment patterns and survival in patients with hepatocellular carcinoma in the Swedish national registry SweLiv by Henriksson, M., Björnsson, B., Sternby Eilard, M., Lindell, G., Strömberg, C., Hemmingsson, O., Isaksson, B., Rizell, M., Sandström, P.

“…Background Consistent data on clinical features, treatment modalities and long‐term survival in patients with hepatocellular carcinoma (HCC) using nationwide…”
Get full text

Post-nephrectomy development of renal function in living kidney donors: a cross-sectional retrospective study by Fehrman-Ekholm, Ingela, Kvarnström, Niclas, Söfteland, John M., Lennerling, Annette, Rizell, Magnus, Odén, Anders, Simonsson, Tomas

“…Background. Increasing numbers of living donor kidney transplantations calls for better knowledge about long-term donor outcomes and risks. Methods. To explore…”
Get full text

Vasopressin and nitroglycerin decrease portal and hepatic venous pressure and hepato‐splanchnic blood flow by Wisén, E., Svennerholm, K., Bown, L. S., Houltz, E., Rizell, M., Lundin, S., Ricksten, S.‐E.

“…Background Various methods are used to reduce venous blood pressure in the hepato‐splanchnic circulation, and hence minimise blood loss during liver surgery…”
Get full text

Patterns and resectability of colorectal cancer recurrences: outcome study within the COLOFOL trial by Hansdotter, P, Scherman, P, Petersen, S H, Mikalonis, M, Holmberg, E, Rizell, M, Naredi, P, Syk, I

“…Improvements in surgery, imaging, adjuvant treatment, and management of metastatic disease have led to modification of previous approaches regarding the risk…”
Get full text

A phase Ib randomized multicenter trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab for uveal melanoma metastases (SCANDIUM II trial) by Olofsson Bagge, R., Nelson, A., Shafazand, A., Cahlin, C., Carneiro, A., Helgadottir, H., Levin, M., Rizell, M., Ullenhag, G., Wirén, S., Lindnér, P., Nilsson, J.A., Ny, L.

“…Uveal melanoma (UM) is a rare malignancy where 50% of patients develop metastatic disease primarily affecting the liver. Approximately 40% of patients with…”
Get full text

Response to “ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases” by Sandström, Per, Røsok, Bård I, Sparrelid, Ernesto, Larsen, Peter Nørgaard, Larsson, Anna Lindhoff, Lindell, Gert, Schultz, Nicolai A, Bjørnbeth, Bjorn A, Isaksson, Bengt, Rizell, M, Björnsson, Bergthor

Get full text

Effect of patient position and PEEP on hepatic, portal and central venous pressures during liver resection by SAND, L., RIZELL, M., HOULTZ, E., KARLSEN, K., WIKLUND, J., ODENSTEDT HERGÈS, H., STENQVIST, O., LUNDIN, S.

“…Background It has been suggested that blood loss during liver resection may be reduced if central venous pressure (CVP) is kept at a low level. This can be…”
Get full text

A phase Ib randomized multicenter trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab for uveal melanoma by Olofsson Bagge, Roger, Nelson, Axel, Shafazand, A., Cahlin, Christian, Carneiro, A., Helgadottir, H., Levin, Max, Rizell, Magnus, Ullenhag, G., Wiren, S., Lindner, Per, Nilsson, Jonas A, Ny, Lars

“…Background: Uveal melanoma (UM) is a rare malignancy where 50% of patients develop metastatic disease primarily affecting the liver. Approximately 40% of…”
Get full text

Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection by Sand Bown, L., Ricksten, S.-E., Houltz, E., Einarsson, H., Söndergaard, S., Rizell, M., Lundin, S.

“…Background To minimize blood loss during hepatic surgery, various methods are used to reduce pressure and flow within the hepato‐splanchnic circulation. In…”
Get full text

Vasopressin and nitroglycerin decrease portal and hepatic venous pressure and hepato‐splanchnic blood flow by Wisén, E., Svennerholm, K., Sand Bown, L., Houltz, E., Rizell, M., Lundin, S., Ricksten, S.‐E.

Get full text

Donor Monoclonal Gammopathy May Cause Lymphoproliferative Disorders in Solid Organ Transplant Recipients by Felldin, M., Ekberg, J., Polanska‐Tamborek, D., Hansson, U., Sender, M., Rizell, M., Svanvik, J., Mölne, J.

“…Prior research on donor monoclonal gammopathy of undetermined significance (MGUS) has been inadequate regarding the risk for lymphoproliferative disease in…”
Get full text

Nitroglycerine and patient position effect on central, hepatic and portal venous pressures during liver surgery by SAND, L, LUNDIN, S, RIZELL, M, WIKLUND, J, STENQVIST, O, HOULTZ, E

“…Background To reduce blood loss during liver surgery, a low central venous pressure (CVP) is recommended. Nitroglycerine (NG) with its rapid onset and offset…”
Get full text

Hepatocellular carcinoma in Sweden – Data from the Swedish National Liver Registry, SweLiv by Rizell, M, Gunnarsdottir, K, Noren, A, Isaksson, B, Ardnor, B, Lindell, G, Sandstrom, P.A

Get full text

Survival after resection for non-colorectal liver metastases – As good as for colorectal metastases – A national registry based study (SweLiv) by Lindell, G, Gunnarsdottir, K, Rizell, M, Norén, A, Isaksson, B, Ardnor, B, Sandström, P

Get full text

The impact of post-hepatectomy liver failure (PHLF) on mortality – A population based study by Gilg, S, Sandström, P, Rizell, M, Norén, A, Lindell, G, Ardnor, B, Nowak, G, Strömberg, C, Isaksson, B

Get full text

Survival and recurrence of hepatocellular carcinoma in Sweden after curatively aiming treatments by Rizell, M, Ardnor, B, Isaksson, B, Noren, A, Soderdahl, G, Sandstrom, P, Lindell, G, Sternby, M, Gunnarsdottir, K

Get full text

Chemoembolization as selection tool for liver transplantation in hepatocellular carcinoma (HCC) above UCSF criteria – a national down staging study by Rizell, M, Stal, P, Sternby, M, Sandstrom, P, Noren, A, Ardnor, B, Lindell, G, Soderdahl, G

Get full text